Pfizer Asks For Biden’s Co-operation To Incentivize Biosimilar Uptake

As Company’s Biosimilars Turnover Grows By Over 80% In Q1

 
• By Akriti Seth
  
US_Pfizer
Pfizer says it is working with the Biden administration for solutions for patient access • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business